Europe Ovarian Cancer Market Size & Outlook, 2025-2033


Europe Ovarian Cancer Market Insights

  • As per Reed Intelligence insights, Europe’s Ovarian Cancer Market was valued at USD 423.37 Million in 2024 and is anticipated to expand to USD 2573.76 Million by 2033.
  • From 2026 to 2033, the market is anticipated to expand at a CAGR of 22.41%.
  • Within By Type, Epithelial Tumors accounted for the largest market size in 2024.
  • During the forecast period, Primary Peritoneal Cancer is anticipated to remain the highest-growth segment within the By Type category.

Other Key Findings


  • Europe held 31.36% share of the global Ovarian Cancer Market size in 2024.
  • United States is expected to remain the largest contributor to the global market size by 2033.
  • By 2033, Benelux is anticipated to record the highest growth in Europe, with the market size expected to reach USD 142.32 Million.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 423.37 Million
Market Size In 2033 USD 2573.76 Million
Largest segment Epithelial Tumors
Units Revenue in USD Million
CAGR 22.41% (2025-2033)
Segmnetation Covered
Europe
  1. Germany
  2. United Kingdom
  3. France
  4. Italy
  5. Spain
  6. Russia
  7. Nordic
  8. Benelux
By Type
  1. Epithelial Tumors
  2. Germ Cell Tumors
  3. Stromal Tumors
  4. Primary Peritoneal Cancer
By Diagnosis
  1. Computed Tomography (C.T.) Scans
  2. Ultrasound
  3. Barium Enema X-Ray
  4. Magnetic Resonance Imaging (MRI) Scans
  5. Chest X-Ray
  6. Positron Emission Tomography (PET) Scan
  7. Other Diagnostic Tests
By Therapeutic Treatment
  1. Chemotherapy
  2. Radiation Therapy
  3. Targeted Therapy
  4. Hormone Therapy
  5. Other Therapeutic Treatments
  6. Surgery
By Route of Administration
  1. Oral
  2. Parenteral
  3. Others
By Drugs
  1. Mitotic Inhibitors
  2. Antirheumatics
  3. Antipsoriatics
  4. VEGF/VEGFR inhibitors
  5. PARP inhibitors
  6. Antineoplastics
  7. Others
By End-User
  1. Hospitals
  2. Diagnostic Centers
  3. Drug Stores
  4. Online Pharmacies
  5. Other End Users
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends